Core Viewpoint - Kanghui Co., Ltd. announced that as of the disclosure date, its subsidiary, Chunsheng Pharmaceutical, has applied for an 8 million yuan loan from Tianfu Bank, which has not yet been drawn [1] Group 1: Loan and Guarantees - The total amount of guarantees provided by the company for its controlling subsidiaries (including controlling grand-subsidiaries) is 87.0329 million yuan [1] - The guarantees provided by the controlling subsidiary to its wholly-owned subsidiary amount to 2.8 million yuan [1] - The total guarantees provided by the company and its controlling subsidiaries amount to 89.8329 million yuan, which represents 10.48% of the company's latest audited net assets attributable to shareholders as of the end of 2024 [1] Group 2: Future Implications - If Chunsheng Pharmaceutical draws the aforementioned 8 million yuan loan, the total guarantees provided by the company and its controlling subsidiaries will increase to 97.8329 million yuan, representing 11.41% of the company's latest audited net assets attributable to shareholders as of the end of 2024 [1] - The company does not provide guarantees for entities outside of its controlling subsidiaries (including controlling grand-subsidiaries) [1] - There are no overdue guarantees from the company or its controlling subsidiaries (including controlling grand-subsidiaries) [1]
康惠股份:公司及控股子公司(含控股孙公司)不存在逾期担保情形